Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- And antiinflammatory responses in mice with pseudomonas aeruginosa lung infection

Journal of Nutrition

Volumn 139, Issue 1, 2009, Pages 82-89

  Tiesset, Helène ^a,c   Pierre, Maud ^a,c   Desseyn, Jean Luc ^b,d   Guery, Benoît ^b,c,e   Beermann, Christopher ^f,g   Galabert, Claude ^h   Gottrand, Frederic ^a,c   Husson, Marie Odile ^a,c  

^a Faculty of Medicine   (France)

^b IFR114 IMPRT   (France)

^c UNIV LILLE   (France)

^d JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^e France Institut Pasteur de Lille   (France)

^f Danone Research Center of Specialized Nutrition   (Germany)

^g University of Applied Science Fulda   (Germany)

^h Hopital Renee Sabran   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; DOCOSAHEXAENOIC ACID; I KAPPA B ALPHA; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNE RESPONSE; LUNG CLEARANCE; LUNG INFECTION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DIET; FATTY ACIDS, OMEGA-3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEURTURIN; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TIME;

BACTERIA (MICROORGANISMS); MUS; PSEUDOMONAS AERUGINOSA;

EID: 58649097739     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.096115     Document Type: Article

References (49)

1. Robinson DR, Xu LL, Tateno S, Guo M, Colvin RB. Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res. 1993;34: 1435-44.
2. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505.
3. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60:502-7.
4. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:S1505-19.
5. Chapkin RS, Hubbard NE, Erickson KL. 5-Series peptido-leukotriene synthesis in mouse peritoneal macrophages: modulation by dietary n-3 fatty acids. Biochem Biophys Res Commun. 1990;171:764-9.
6. Whelan J, Broughton KS, Lokesh B, Kinsella JE. In vivo formation of leukotriene E5 by murine peritoneal cells. Prostaglandins. 1991;41: 29-42.
7. Hawkes JS, James MJ, Cleland LG. Biological activity of prostaglandin E3 with regard to oedema formation in mice. Agents Actions. 1992;35: 85-7.
8. Murakami K, Bujo H, Unoki H, Saito Y. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes. Eur J Pharmacol. 2007;561:206-13.
9. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2007;77:327-35.
10. Collie-Duguid ES, Wahle KW. Inhibitory effect of fish oil N-3 polyun\ saturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun. 1996;220:969-74.
11. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br J Nutr. 2002;87 Suppl 1:S31-48.
12. Reddy RC, Keshamouni VG, Jaigirdar SH, Zeng X, Leff T, Thannickal VJ, Standiford TJ. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. Am J Physiol Lung Cell Mol Physiol. 2004;286:L613-9.
13. Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771:926-35.
14. von Knethen A, Soller M, Brune B. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis. Arch Immunol Ther Exp (Warsz). 2007;55:19-25.
15. Anderson M, Fritsche KL. (n-3) Fatty acids and infectious disease resistance. J Nutr. 2002;132:3566-76.
16. Pierre M, Husson MO, Le Berre R, Desseyn JL, Galabert C, Beghin L, Beermann C, Dagenais A, Berthiaume Y, et al. Omega-3 polyunsatu-rated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1422-31.
17. Tetaert D, Pierre M, Demeyer D, Husson MO, Beghin L, Galabert C, Gottrand F, Beermann C, Guery B, et al. Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa. Respir Res. 2007;8:39.
18. Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev. 2002;3:128-34.
19. Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, Hug C, Pilet M, Roulet M. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr. 2006;25: 418-27.
20. Victor VM, Rocha M, De la FM. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol. 2004;4:327-47.
21. Demir M, Sert S, Kaleli I, Demir S, Cevahir N, Yildirim U, Sahin B. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition. Med Sci Monit. 2007;13:BR225-9.
22. Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem. 2000;275:36703-7.
23. Patel VI, Daniel S, Longo CR, Shrikhande GV, Scali ST, Czismadia E, Groft CM, Shukri T, Motley-Dore C, et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J. 2006;20:1418-30.
24. Davies S, Dai D, Feldman I, Pickett G, Leslie KK. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. Gynecol Oncol. 2004;94: 463-70.
25. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-kappaB and JNK: an intricate affair. Cell Cycle. 2004;3:1524-9.
26. Schaecher K, Goust JM, Banik NL. The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res. 2004;29:1443-51.
27. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma. 1996;40:613-6.
28. Xue ML, Zhu H, Willcox M, Wakefield D, Lloyd A, Thakur A. The role of IL-1beta in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr Eye Res. 2001;23:406-14.
29. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127:S838-41.
30. Peck MD, Alexander JW, Ogle CK, Babcock GF. The effect of dietary fatty acids on response to Pseudomonas infection in burned mice. J Trauma. 1990;30:445-52.
31. Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Urman S, Zaman M, Morrow JD, Alvarez JG. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. J Appl Physiol. 2002;92:2169-76.
32. Power MR, Marshall JS, Yamamoto M, Akira S, Lin TJ. The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice. Clin Exp Immunol. 2006;146:323-9.
33. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol. 2005;3:281-94.
34. Fan YY, McMurray DN, Ly LH, Chapkin RS. Dietary (n-3) polyun- saturated fatty acids remodel mouse T-cell lipid rafts. J Nutr. 2003;133: 1913-20.
35. Fan YY, Ly LH, Barhoumi R, McMurray DN, Chapkin RS. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J Immunol. 2004;173:6151-60.
36. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126:1-27.
37. Shaikh SR, Cherezov V, Caffrey M, Stillwell W, Wassall SR. Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidyl-ethanolamine: trigger for microdomain/raft formation? Biochemistry. 2003;42:12028-37.
38. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny P, Waldhausl W. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem. 2001;276:37335-40.
39. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003;44:479-86.
40. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem. 2003;278:37041-51.
41. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 2005;67:867-74.
42. Weldon SM, MullenAC, Loscher CE, HurleyLA, Roche HM. Docosahex- aenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem. 2007;18:250-8.
43. Auvin S, Collet F, Gottrand F, Husson MO, Leroy X, Beermann C, Guery BP. Long-chain polyunsaturated fatty acids modulate lunginflammatory response induced by Pseudomonas aeruginosa in mice. Pediatr Res. 2005;58:211-5.
44. Sher T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, hromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 1993;32:5598-604.
45. Mukherjee R, Jow L, Noonan D, McDonnell DP. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol. 1994;51:157-66.
46. Mukherjee R, Jow L, Croston GE, Paterniti JR Jr. Identification, characterization, and tissue distribution of human peroxisome prolifer-ator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgam-ma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem. 1997;272:8071-6.
47. Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE, Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun. 1996;224:431-7.
48. Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, Genovese T, Muia C, Crisafulli C, et al. The role of the peroxisome proliferator- activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J Leukoc Biol. 2006;79:999-1010.
49. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, Hainque B, Riou JP, Laville M, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res. 2002;10:518-25.